DEVONIAN HEALTH GROUP INC (GSD.CA) Fundamental Analysis & Valuation

TSX-V:GSD • CA2518348834

Current stock price

10.01 CAD
-1.99 (-16.58%)
Last:

This GSD.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. GSD.CA Profitability Analysis

1.1 Basic Checks

  • In the past year GSD has reported negative net income.
  • In the past year GSD has reported a negative cash flow from operations.
  • GSD had negative earnings in each of the past 5 years.
  • In the past 5 years GSD reported 4 times negative operating cash flow.
GSD.CA Yearly Net Income VS EBIT VS OCF VS FCFGSD.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M 4M -4M -6M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -44.73%, GSD is doing worse than 78.79% of the companies in the same industry.
  • GSD has a worse Return On Equity (-72.55%) than 69.70% of its industry peers.
Industry RankSector Rank
ROA -44.73%
ROE -72.55%
ROIC N/A
ROA(3y)-22.64%
ROA(5y)-21.36%
ROE(3y)-37.09%
ROE(5y)-35.39%
ROIC(3y)N/A
ROIC(5y)N/A
GSD.CA Yearly ROA, ROE, ROICGSD.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60

1.3 Margins

  • Looking at the Gross Margin, with a value of 38.40%, GSD is in line with its industry, outperforming 51.52% of the companies in the same industry.
  • GSD's Gross Margin has improved in the last couple of years.
  • GSD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 38.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.24%
GM growth 5YN/A
GSD.CA Yearly Profit, Operating, Gross MarginsGSD.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. GSD.CA Health Analysis

2.1 Basic Checks

  • GSD does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for GSD remains at a similar level compared to 1 year ago.
  • GSD has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for GSD has been reduced compared to a year ago.
GSD.CA Yearly Shares OutstandingGSD.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M 2M
GSD.CA Yearly Total Debt VS Total AssetsGSD.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

2.2 Solvency

  • GSD has an Altman-Z score of 1.57. This is a bad value and indicates that GSD is not financially healthy and even has some risk of bankruptcy.
  • GSD has a Altman-Z score of 1.57. This is in the better half of the industry: GSD outperforms 75.76% of its industry peers.
  • A Debt/Equity ratio of 0.01 indicates that GSD is not too dependend on debt financing.
  • GSD has a better Debt to Equity ratio (0.01) than 87.88% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 1.57
ROIC/WACCN/A
WACC8.76%
GSD.CA Yearly LT Debt VS Equity VS FCFGSD.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M 10M 15M

2.3 Liquidity

  • GSD has a Current Ratio of 1.44. This is a normal value and indicates that GSD is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.44, GSD is in line with its industry, outperforming 45.45% of the companies in the same industry.
  • A Quick Ratio of 1.43 indicates that GSD should not have too much problems paying its short term obligations.
  • The Quick ratio of GSD (1.43) is better than 63.64% of its industry peers.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 1.43
GSD.CA Yearly Current Assets VS Current LiabilitesGSD.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. GSD.CA Growth Analysis

3.1 Past

  • GSD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -298.54%.
  • Looking at the last year, GSD shows a very negative growth in Revenue. The Revenue has decreased by -23.32% in the last year.
  • The Revenue has been growing by 61.56% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-298.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-135.04%
Revenue 1Y (TTM)-23.32%
Revenue growth 3Y117.11%
Revenue growth 5Y61.56%
Sales Q2Q%-82.81%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GSD.CA Yearly Revenue VS EstimatesGSD.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

More info and screens

Find the best growth stocksShow best growing peers

0

4. GSD.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for GSD. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GSD.CA Price Earnings VS Forward Price EarningsGSD.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GSD.CA Per share dataGSD.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. GSD.CA Dividend Analysis

5.1 Amount

  • GSD does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

GSD.CA Fundamentals: All Metrics, Ratios and Statistics

DEVONIAN HEALTH GROUP INC

TSX-V:GSD (4/13/2026, 7:00:00 PM)

10.01

-1.99 (-16.58%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-26
Earnings (Next)06-24
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners12.08%
Ins Owner ChangeN/A
Market Cap27.73M
Revenue(TTM)18.52M
Net Income(TTM)-6.97M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.5
P/FCF N/A
P/OCF N/A
P/B 2.89
P/tB 5.9
EV/EBITDA N/A
EPS(TTM)-2.75
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-2.24
FCFYN/A
OCF(TTM)-2.24
OCFYN/A
SpS6.69
BVpS3.47
TBVpS1.7
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -44.73%
ROE -72.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 38.4%
FCFM N/A
ROA(3y)-22.64%
ROA(5y)-21.36%
ROE(3y)-37.09%
ROE(5y)-35.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.24%
GM growth 5YN/A
F-Score4
Asset Turnover1.19
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.44
Quick Ratio 1.43
Altman-Z 1.57
F-Score4
WACC8.76%
ROIC/WACCN/A
Cap/Depr(3y)1.89%
Cap/Depr(5y)3.25%
Cap/Sales(3y)0.03%
Cap/Sales(5y)0.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-298.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-135.04%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-23.32%
Revenue growth 3Y117.11%
Revenue growth 5Y61.56%
Sales Q2Q%-82.81%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-256.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-67.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-67.14%
OCF growth 3YN/A
OCF growth 5YN/A

DEVONIAN HEALTH GROUP INC / GSD.CA Fundamental Analysis FAQ

What is the fundamental rating for GSD stock?

ChartMill assigns a fundamental rating of 2 / 10 to GSD.CA.


What is the valuation status of DEVONIAN HEALTH GROUP INC (GSD.CA) stock?

ChartMill assigns a valuation rating of 0 / 10 to DEVONIAN HEALTH GROUP INC (GSD.CA). This can be considered as Overvalued.


What is the profitability of GSD stock?

DEVONIAN HEALTH GROUP INC (GSD.CA) has a profitability rating of 1 / 10.


Can you provide the financial health for GSD stock?

The financial health rating of DEVONIAN HEALTH GROUP INC (GSD.CA) is 4 / 10.